Nina Kim
8PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.Nina Kim, E Dianne Pulte, Lori A Ehrlich
|Jan 09, 2025
Advancing drug development in myelodysplastic syndromes.Alain Mina, Kathy L McGraw, Lea Cunningham
|Jan 23, 2023
Considerations for Drug Development in Myelodysplastic Syndromes.Mikkael A Sekeres, Nina Kim, Amy E DeZern
|Nov 06, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms.Mrinal M Patnaik, Amer M Zeidan, Eric Padron
|Oct 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein
|Oct 19, 2022
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei
Pageof 2
Frequent Collaborators
5 joint publications
Rami S Komrokji
4 joint publications
Lori A Ehrlich
4 joint publications
Mikkael Sekeres
3 joint publications
Kelly J Norsworthy
3 joint publications
Richard F Little
3 joint publications
Michael Savona
3 joint publications
Zhuoer Xie
3 joint publications
Justin Taylor
3 joint publications
Hetty E Carraway
3 joint publications
Mrinal M Patnaik
